Month: November 2012

Extending Product Protection, What About Geriatric Exclusivity?

This is the first in a series of posts which emphasizes how life science product manufacturers should be cognizant of the growing elderly population and the opportunity that it affords. This inaugural post of the series discusses the potential for obtaining geriatric exclusivity for certain marketed pharmaceutical products. Most companies are familiar with filing for
Details